FranceFrance

Bio-people

26.11.2005

Neurotech S.A. (Paris, France) has named Ted Danse as new President and Chief Executive Officer. Danse has a record of more than 25 years in life science industries. He served as President and CEO of the public US ophthalmic pharmaceutical company ISTA Pharmaceuticals Inc. and was Director on the boards of Quest Vision Technologies, Inc. and Vision Solutions Technologies, Inc. Other stations of his carreer include business development roles at Coopervision, Bausch & Lomb, Schering-Plough and Allergan.

FranceFrance

04.11.2010

Paris – Genome engineering specialist Cellectis has signed the first licence for the use of induced pluripotent stem (iPS) cells in the development of human regenerative medicines with their inventor Shinya Yamanaka of the Centre...

FranceFrance

04.11.2010

Paris – French-based Stentys S.A. has raised EUR 22.7m through the sale of 1.9 million shares at EUR 12 in an Initial Public Offering on the Euronext Paris and a private placement outside the United States. The price came in at...

FranceFrance

04.11.2010

Strasbourg – For two years, consumer organisations and members of the European Parliament have pressed not to allow pharmaceutical companies to provide information on their prescription medicines directly to consumers as proposed...

FranceFrance

01.11.2010

Exactly two years ago, DNP Green Technology (www.dnpgreen.com) and Agro-industries Recherches et Développements (www.a-r-d.fr) officially announced that they were forming the joint venture Bioamber S.A.S (www.bioamber.com) with...

FranceFrance

01.11.2010

Valbonne – French researcher, together with the Californian vaccine firm Dynavax Technology, have provided the proof-of–principle for a new vaccination strategy against allergic asthma (Nature Medicine, doi:10.1038/nm.2253). They...

FranceFrance

22.10.2010

Toulouse – French Cerenis Therapeutics has raised an additional EUR10 million in a second closing of its Series C financing, taking the total funds raised in the Series C to EUR50 million. The company said it will fund Phase II...

FranceFrance

21.10.2010

Paris – A French-US research team (multiple French research institutes and Mount Sinai School of Medicine, New York, under INSERM director Nicolae Ghinea) has potentially identified the ultimate cancer biomarker. Analysis of data...

FranceFrance

05.10.2010

Paris - Sanofi-Aventis has made a new bid to acquire all outstanding shares of the US-biotech firm Genzyme Corporation for $69 per share, after " the Genzyme management refused any constructive talks" according to Sanofi's CEO...

FranceFrance

17.09.2010

Sophia Antipolis – French NicOx S.A. and Merck & Co. Inc. announced they will follow a new strategy to nitric oxide (NO) donating compounds as a result of new findings during the course of their joint research program. After...

Displaying results 51 to 60 out of 268

< Previous 51-60 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive-france/browse/5/article/bio-people-2.html

Events

All Events

Stock list

All quotes

TOP

  • BIOINVENT INTERNATIONAL AB (S)3.10 SEK9.15%
  • Allergy Therapeutics (UK)19.12 GBP6.94%
  • PHARMING (NL)0.48 EUR6.67%

FLOP

  • ANTISOMA (UK)1.32 GBP-14.84%
  • XENETIC BIOSCIENCES (UK)6.00 GBP-14.29%
  • CHRONTECH PHARMA (S)0.07 SEK-12.50%

TOP

  • WILEX (D)3.15 EUR314.5%
  • SANTHERA (CH)68.55 CHF90.4%
  • ADDEX (CH)4.08 CHF82.1%

FLOP

  • MERCK KGAA (D)65.43 EUR-48.6%
  • HYBRIGENICS (F)1.83 EUR-26.8%
  • PROSENSA (NL)9.48 USD-25.2%

TOP

  • SANTHERA (CH)68.55 CHF3489.0%
  • GW PHARMACEUTICALS (UK)427.00 GBP729.1%
  • PAION (D)2.79 EUR316.4%

FLOP

  • CYTOS (CH)0.26 CHF-92.4%
  • EVOCUTIS (UK)0.21 GBP-91.8%
  • PROSENSA (NL)9.48 USD-68.0%

No liability assumed, Date: 25.07.2014

Job Advert

Executive Director of the IMI Joint Undertaking

The Innovative Medicines Initiative Joint Undertaking (IMI JU) is a public-private partnership between the European Commission and the European Federation of Pharmaceutical Industries Associations (EFPIA).
The Executive Director will lead and manage the Joint Undertaking and take overall responsibility for its operations ensuring the achievement of the Joint Undertaking's objectives. more...


Current issue

All issues

Product of the week

Products